Top

Published in:

01-12-2019 | Urography | Special Section: Urothelial Disease

Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology

Authors: Jacob L. Roberts, Fady Ghali, Lejla Aganovic, Seth Bechis, Kelly Healy, Gerant Rivera-Sanfeliz, Riccardo Autorino, Ithaar Derweesh

Published in: Abdominal Radiology | Issue 12/2019

Abstract

Upper tract urothelial carcinoma (UTUC) is a common and lethal malignancy. Patients diagnosed with this illness often face invasive workups, morbid therapies, and prolonged post-operative surveillance. UTUC represents approximately 5–10% of urothelial malignancies in the United States and affect 4600–7800 new patients annually. Various environmental exposures as well as smoking have been implicated in the development of UTUC. The diagnosis and workup of UTUC relies on heavily on imaging studies, a close working relationship between Urologists and Radiologists, and invasive procedures such as ureteroscopy. Treatments range from renal-sparing endoscopic surgery to radical extirpative surgery depending on the specific clinical situation. Follow-up is crucial as UTUC has a high recurrence rate. Here we review the epidemiology, diagnosis, management strategies, and follow-up of UTUC from an interdisciplinary perspective.

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.

Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA: A Cancer Journal for Clinicians 67:7–30. https://doi.org/10.3322/caac.21387 CrossRef

Kim DK, Lee JY, Kim JW, Hah YS, Cho KS (2019) Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 135:59–65. https://doi.org/10.1016/j.critrevonc.2019.01.019 CrossRefPubMed

Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG (2009) Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115:1224–1233. https://doi.org/10.1002/cncr.24135 CrossRefPubMed

Pham MN, Apolo AB, De Santis M, Galsky MD, Leibovich BC, Pisters LL, Siefker-Radtke AO, Sonpavde G, Steinberg GD, Sternberg CN, Tagawa ST, Weizer AZ, Woods ME, Milowsky MI (2017) Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World J Urol 35:367–378. https://doi.org/10.1007/s00345-016-1885-4 CrossRefPubMed

Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. European Urology 73:111–122. https://doi.org/10.1016/j.eururo.2017.07.036 CrossRefPubMed

Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–1525CrossRef

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492 CrossRefPubMed

Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V, Upper-Tract Urothelial Carcinoma Collaborative Group (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29:716–723. https://doi.org/10.1016/j.urolonc.2009.11.007 CrossRef

10.

Miyazaki J, Nishiyama H (2017) Epidemiology of urothelial carcinoma. International Journal of Urology 24:730–734. https://doi.org/10.1111/iju.13376 CrossRefPubMed

11.

Cosentino M, Palou J, Gaya JM, Breda A, Rodriguez-Faba O, Villavicencio-Mavrich H (2013) Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 31:141–145. https://doi.org/10.1007/s00345-012-0877-2 CrossRefPubMed

12.

Holmäng S, Johansson SL (2004) Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 101:741–747. https://doi.org/10.1002/cncr.20395 CrossRefPubMed

13.

Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF (2014) Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol 65:742–754. https://doi.org/10.1016/j.eururo.2013.06.010 CrossRefPubMed

14.

Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, Rouprêt M (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU International 104:1436–1440. https://doi.org/10.1111/j.1464-410x.2009.08838.x CrossRefPubMed

15.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S (2004) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110:598–604. https://doi.org/10.1002/ijc.20157 CrossRefPubMed

16.

McLaughlin JK, Silverman DT, Hsing AW, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ, Fraumeni JF (1992) Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52:254–257PubMed

17.

Shinka T, Miyai M, Sawada Y, Inagaki T, Okawa T (1995) Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int J Urol 2:243–248CrossRef

18.

Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelaković B (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 104:12129–12134. https://doi.org/10.1073/pnas.0701248104 CrossRefPubMed

19.

Chen C-H, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, Gnatenko DV, Wu L, Turesky RJ, Wu X-R, Pu Y-S, Grollman AP (2012) Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci USA 109:8241–8246. https://doi.org/10.1073/pnas.1119920109 CrossRefPubMed

20.

Browne BM, Stensland KD, Moynihan MJ, Canes D (2018) An Analysis of Staging and Treatment Trends for Upper Tract Urothelial Carcinoma in the National Cancer Database. Clin Genitourin Cancer 16:e743–e750. https://doi.org/10.1016/j.clgc.2018.01.015 CrossRefPubMed

21.

Inman BA, Tran V-T, Fradet Y, Lacombe L (2009) Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer 115:2853–2862. https://doi.org/10.1002/cncr.24339 CrossRefPubMed

22.

Cowan NC (2012) CT urography for hematuria. Nat Rev Urol 9:218–226. https://doi.org/10.1038/nrurol.2012.32 CrossRefPubMed

23.

Jinzaki M, Kikuchi E, Akita H, Sugiura H, Shinmoto H, Oya M (2016) Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. International Journal of Urology 23:284–298. https://doi.org/10.1111/iju.13032 CrossRefPubMed

24.

CT Urography Working Group of the European Society of Urogenital Radiology (ESUR), Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, Nolte-Ernsting CCA, Takahashi S, Cohan RH (2008) CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol 18:4–17. https://doi.org/10.1007/s00330-007-0792-x CrossRef

25.

Takahashi Naoki, Glockner James F., Hartman Robert P., King Bernard F., Leibovich Bradley C., Stanley David W., Fitz-Gibbon Patrick D., Kawashima Akira (2010) Gadolinium Enhanced Magnetic Resonance Urography for Upper Urinary Tract Malignancy. Journal of Urology 183:1330–1336. https://doi.org/10.1016/j.juro.2009.12.031 CrossRef

26.

Sudah M, Masarwah A, Kainulainen S, Pitkänen M, Matikka H, Dabravolskaite V, Aaltomaa S, Vanninen R (2016) Comprehensive MR Urography Protocol: Equally Good Diagnostic Performance and Enhanced Visibility of the Upper Urinary Tract Compared to Triple-Phase CT Urography. PLoS One 11. https://doi.org/10.1371/journal.pone.0158673 CrossRefPubMedPubMedCentral

27.

Drudi FM, Candio GD, Leo ND, Malpassini F, Gnecchi M, Cantisani V, Iori F, Liberatore M (2013) Contrast-Enhanced Ultrasonography in the Diagnosis of Upper Urinary Tract Urothelial Cell Carcinoma: A Preliminary Study. Ultraschall in Med 34:30–37. https://doi.org/10.1055/s-0032-1325548 CrossRef

28.

Rojas CP, Castle SM, Llanos CA, Cortes JAS, Bird V, Rodriguez S, Reis IM, Zhao W, Gomez-Fernandez C, Leveillee RJ, Jorda M (2013) Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations 31:1696–1700. https://doi.org/10.1016/j.urolonc.2012.05.010 CrossRefPubMed

29.

Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU International 110:614–628. https://doi.org/10.1111/j.1464-410x.2012.11068.x CrossRefPubMed

30.

Oitchayomi A, Doerfler A, Le Gal S, Chawhan C, Tillou X (2016) Flexible and rigid ureteroscopy in outpatient surgery. BMC Urol 16. https://doi.org/10.1186/s12894-016-0124-z CrossRefPubMedPubMedCentral

31.

Tanimoto R, Cleary RC, Bagley DH, Hubosky SG (2016) Ureteral Avulsion Associated with Ureteroscopy: Insights from the MAUDE Database. J Endourol 30:257–261. https://doi.org/10.1089/end.2015.0242 CrossRefPubMed

32.

Pan S, Smith AD, Motamedinia P (2017) Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer. Journal of Endourology 31:238–245. https://doi.org/10.1089/end.2016.0475 CrossRefPubMed

33.

Petros FG, Li R, Matin SF (2018) Endoscopic Approaches to Upper Tract Urothelial Carcinoma. Urologic Clinics of North America 45:267–286. https://doi.org/10.1016/j.ucl.2017.12.009 CrossRefPubMed

34.

Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High Rate of Pathologic Upgrading at Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology 79:615–619. https://doi.org/10.1016/j.urology.2011.11.049 CrossRefPubMed

35.

Liu P, Su X, Xiong G-Y, Li X-S, Zhou L-Q (2016) Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy. Int Braz J Urol 42:1129–1135. https://doi.org/10.1590/s1677-5538.ibju.2015.0366 CrossRefPubMedPubMedCentral

36.

Lee H-Y, Yeh H-C, Wu W-J, He J-S, Huang C-N, Ke H-L, Li W-M, Li C-F, Li C-C (2018) The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence. World J Surg Oncol 16. https://doi.org/10.1186/s12957-018-1411-9 CrossRefPubMedPubMedCentral

37.

Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP, Cha EK, Yee A, Friedman FM, Sjoberg DD, Ehdaie B, Coleman J (2016) Impact of Ureteroscopy Prior to Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes. Urology 94:148–153. https://doi.org/10.1016/j.urology.2016.05.039 CrossRefPubMedPubMedCentral

38.

Huang SY, Ahrar K, Gupta S, Wallace MJ, Ensor JE, Krishnamurthy S, Matin SF (2015) Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma: Safety and diagnostic accuracy of percutaneous biopsy in UTUC. BJU Int 115:625–632. https://doi.org/10.1111/bju.12824 CrossRefPubMed

39.

Lohela P, Apaja-Sarkkinen M. Needle tract seeding after use of a fine needle to biopsy a renal tumour. Br Med J 1986; 292: 174CrossRef

40.

Cutress Mark L., Stewart Grant D., Tudor Edward C.G., Egong Eric A., Wells-Cole Simon, Phipps Simon, Thomas Ben G., Riddick Antony C.P., McNeill S. Alan, Tolley David A. (2013) Endoscopic Versus Laparoscopic Management of Noninvasive Upper Tract Urothelial Carcinoma: 20-Year Single Center Experience. Journal of Urology 189:2054–2061. https://doi.org/10.1016/j.juro.2012.12.006 CrossRefPubMed

41.

Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Cowan NC, Kaasinen E, Palou J, van Rhijn BWG, Sylvester RJ, Zigeuner R, Shariat SF, Rouprêt M (2016) Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. European Urology 70:1052–1068. https://doi.org/10.1016/j.eururo.2016.07.014 CrossRefPubMed

42.

Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma. Cancer 98:55–60. https://doi.org/10.1002/cncr.11446 CrossRefPubMed

43.

Leow, J. J., Chong, K. T., Chang, S. L. & Bellmunt, J. Upper tract urothelial carcinoma: a different disease entity in terms of management. ESMO Open1, e000126 (2016).CrossRef

44.

Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu J-N, Montorsi F, Traxer O (2016) Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34:1201–1206. https://doi.org/10.1007/s00345-015-1753-7 CrossRefPubMed

45.

De Groote R, Decaestecker K, Larcher A, Buelens S, De Bleser E, D’Hondt F, Schatteman P, Lumen N, Montorsi F, Mottrie A, De Naeyer G, De Naeyer G, Larcher A, Sopena JMG, Pini G, Grivas N, Lantz AW, Everaerts WLM, Goonewardene S, Ploumidis A, the YAU Robotic and Urothelial Group (2019) Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions. J Robotic Surg. https://doi.org/10.1007/s11701-019-00965-8

46.

Ni S, Tao W, Chen Q, Liu L, Jiang H, Hu H, Han R, Wang C (2012) Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol 61:1142–1153. https://doi.org/10.1016/j.eururo.2012.02.019 CrossRefPubMed

47.

Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, Gallucci M (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56:520–526. https://doi.org/10.1016/j.eururo.2009.06.013 CrossRefPubMed

48.

Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche H-M, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF (2011) Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int 108:406–412. https://doi.org/10.1111/j.1464-410x.2010.09826.x CrossRefPubMed

49.

Stonier T, Simson N, Lee S-M, Robertson I, Amer T, Somani BK, Rai BP, Aboumarzouk O (2017) Laparoscopic vs robotic nephroureterectomy: Is it time to re-establish the standard? Evidence from a systematic review. Arab J Urol 15:177–186. https://doi.org/10.1016/j.aju.2017.05.002 CrossRefPubMedPubMedCentral

50.

Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M (2015) A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. European Urology 67:1122–1133. https://doi.org/10.1016/j.eururo.2014.11.035 CrossRefPubMed

51.

Ha Y-S, Chung J-W, Choi SH, Lee JN, Kim BS, Kim T-H, Yoo ES, Kwon TG, Byun S-S, Choi YD, Kang HW, Yun SJ, Kim W-J, Kim HT (2017) Impact of a bladder cuff excision during radical nephroureterectomy on cancer specific survival in patients with upper tract urothelial cancer in Korea: a retrospective, multi-institutional study. Minerva Urol Nefrol 69:466–474. https://doi.org/10.23736/s0393-2249.17.02807-7 CrossRefPubMed

52.

Evans JD, Hansen CC, Tollefson MK, Hallemeier CL (2017) Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report. Adv Radiat Oncol 3:57–61. https://doi.org/10.1016/j.adro.2017.08.012 CrossRefPubMedPubMedCentral

53.

Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD (2010) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7:44–54. https://doi.org/10.1038/nrclinonc.2009.188 CrossRefPubMed

54.

Molina R, Álvarez M, Capilla J, Páez Á (2014) Radiofrequency-Treated Recurrence of Urothelial Carcinoma of the Upper Urinary Tract After Nephroureterectomy. Korean J Urol 55:844–846. https://doi.org/10.4111/kju.2014.55.12.844 CrossRefPubMedPubMedCentral

55.

Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF (2017) Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol 31:946–953. https://doi.org/10.1089/end.2016.0871 CrossRefPubMedPubMedCentral

56.

Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C (2006) Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98:1181–1186. https://doi.org/10.1111/j.1464-410x.2006.06519.x CrossRefPubMed

57.

Novara G, De Marco V, Dalpiaz O, Gottardo F, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V (2008) Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 101:1368–1374. https://doi.org/10.1111/j.1464-410x.2008.07438.x CrossRefPubMed

58.

Shigeta K, Kikuchi E, Hagiwara M, Ando T, Mizuno R, Abe T, Mikami S, Miyajima A, Nakagawa K, Oya M (2017) The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma. The Journal of Urology 198:1278–1285. https://doi.org/10.1016/j.juro.2017.06.073 CrossRefPubMed

59.

Sevillano E, Werner L, Bossé D, Lalani A-KA, Wankowicz SAM, de Velasco G, Farina M, Lundgren K, Choueiri TK, González Del Alba A, Bellmunt J (2017) Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis. Clin Genitourin Cancer 15:e1089–e1094. https://doi.org/10.1016/j.clgc.2017.07.012 CrossRefPubMed

60.

Colin P, Ghoneim TP, Nison L, Seisen T, Lechevallier E, Cathelineau X, Ouzzane A, Zerbib M, Long J-A, Ruffion A, Crouzet S, Cussenot O, Audouin M, Irani J, Gardic S, Gres P, Audenet F, Roumiguié M, Valeri A, Rouprêt M (2014) Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. World J Urol 32:507–512. https://doi.org/10.1007/s00345-013-1116-1 CrossRefPubMed

61.

Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Kobayashi H, Ide H, Miyazaki Y, Obata J, Hoshino K, Shirotake S, Akita H, Kosaka T, Miyajima A, Momma T, Nakagawa K, Hasegawa S, Nakajima Y, Jinzaki M, Oya M (2014) Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location. Ann Surg Oncol 21:1038–1045. https://doi.org/10.1245/s10434-013-3349-z CrossRefPubMed

62.

63.

Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT, Ginzburg S, Uzzo RG, Kutikov A (2014) Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU International 114:216–220. https://doi.org/10.1111/bju.12341 CrossRefPubMedPubMedCentral

64.

65.

Fukushima H, Saito K, Ishioka J, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Sakai Y, Arisawa C, Okuno T, Yonese J, Kamata S, Nagahama K, Noro A, Morimoto S, Tsujii T, Kitahara S, Gotoh S, Higashi Y, Kihara K (2014) Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: A propensity score-matched multicenter study. International Journal of Urology 21:1098–1104. https://doi.org/10.1111/iju.12554 CrossRefPubMed

66.

Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, Taille ADL, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU International 110:1134–1141. https://doi.org/10.1111/j.1464-410x.2012.10960.x CrossRefPubMed

67.

Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker M-O, Gattegno B, Richard F, Cussenot O (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67:1181–1187. https://doi.org/10.1016/j.urology.2005.12.034 CrossRefPubMed

68.

Kim SH, Song MK, Kim JK, Hong B, Kang SH, Ku JH, Jeong BC, Seo HK (2018) Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis. Cancer Res Treat. https://doi.org/10.4143/crt.2018.465 CrossRef

69.

Kim TH, Hong B, Seo HK, Kang SH, Ku JH, Jeong BC (2019) The Comparison of Oncologic Outcomes between Open and Laparoscopic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Korean Multicenter Collaborative Study. Cancer Res Treat 51:240–251. https://doi.org/10.4143/crt.2017.417 CrossRef

70.

Lee H, Kim HJ, Lee SE, Hong SK, Byun S-S (2019) Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma. PLoS One 14. https://doi.org/10.1371/journal.pone.0210401 CrossRefPubMedPubMedCentral

71.

Hu C-Y, Yang C-K, Huang C-Y, Ou Y-C, Hung S-F, Chung S-D, Pu Y-S (2015) Robot-Assisted Laparoscopic Nephroureterectomy versus Hand-Assisted Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: A Matched Comparison Study. Biomed Res Int 2015. https://doi.org/10.1155/2015/918486 CrossRefPubMedPubMedCentral

72.

Trudeau V, Gandaglia G, Shiffmann J, Popa I, Shariat SF, Montorsi F, Perrotte P, Trinh Q-D, Karakiewicz PI, Sun M (2014) Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes. Can Urol Assoc J 8:E695–E701. https://doi.org/10.5489/cuaj.2051 CrossRefPubMedPubMedCentral

Title: Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology
Authors: Jacob L. Roberts
Fady Ghali
Lejla Aganovic
Seth Bechis
Kelly Healy
Gerant Rivera-Sanfeliz
Riccardo Autorino
Ithaar Derweesh
Publication date: 01-12-2019
Publisher: Springer US
Keywords: Urography
Urothelial Cancer
Urothelial Cancer
Published in: Abdominal Radiology / Issue 12/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-019-02293-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2019

Advanced urothelial cancer: a radiology update

The application of cinematic rendering to CT evaluation of upper tract urothelial tumors: principles and practice

CT urography: how to optimize the technique

Imaging of urachal anomalies

Annual short report of the society of abdominal radiology prostate cancer disease-focused panel

Noninvasive liver fibrosis assessment in chronic viral hepatitis C: agreement among 1D transient elastography, 2D shear wave elastography, and magnetic resonance elastography

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage